Evidence method
Level · gp.fundamentals.debt_to_revenue
35.12% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
WST · Jun 30, 2021
WEST PHARMACEUTICAL SERVICES INC. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0000105770-21-000055General Corporate
Evidence method
Level · gp.fundamentals.capex_revenue_ratio
7.86% · OPTIONAL · VALID
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
19.96% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.revenue
37.25% · CORE · VALID
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
47.71% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.gross_margin
43.55% · CORE · VALID
Evidence method
Level · gp.fundamentals.operating_margin
29.20% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
1.91% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
1.42% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History39 statesSelf-history eligible
Mar 31, 201910/10 normalizedLevel 3Jun 30, 201910/10 normalizedLevel 3Sep 30, 201910/10 normalizedLevel 3Dec 31, 20198/8 normalizedLevel 3Mar 31, 20209/9 normalizedLevel 3Jun 30, 20209/9 normalizedLevel 3Sep 30, 20209/9 normalizedLevel 3Dec 31, 20209/9 normalizedLevel 3Mar 31, 20219/9 normalizedLevel 3Jun 30, 20219/9 normalizedLevel 3Sep 30, 20219/9 normalizedLevel 3Dec 31, 20219/9 normalizedLevel 3Mar 31, 20229/9 normalizedLevel 3Jun 30, 20229/9 normalizedLevel 3Sep 30, 20229/9 normalizedLevel 3Dec 31, 20229/9 normalizedLevel 3Mar 31, 20239/9 normalizedLevel 3Jun 30, 20239/9 normalizedLevel 3Sep 30, 20239/9 normalizedLevel 3Sep 30, 20269/9 normalizedLevel 4
Period transition
What moved in the state?
- Previous
- 37.96%
- Current
- 35.12%
- Delta
- -2.84%
- Previous
- 8.16%
- Current
- 7.86%
- Delta
- -0.29%
- Previous
- 13.22%
- Current
- 19.96%
- Delta
- 6.73%
- Previous
- 36.46%
- Current
- 37.25%
- Delta
- 0.79%
- Previous
- 46.25%
- Current
- 47.71%
- Delta
- 1.46%
- Previous
- 40.54%
- Current
- 43.55%
- Delta
- 3.01%
- Previous
- 26.18%
- Current
- 29.20%
- Delta
- 3.02%
- Previous
- 1.82%
- Current
- 1.91%
- Delta
- 0.09%
- Previous
- 0.88%
- Current
- 1.42%
- Delta
- 0.54%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · WST Fundamental State →Has State · WEST PHARMACEUTICAL SERVICES INC →Transitioned To · WST Fundamental State →Transitioned To · WST BALANCE_SHEET_LEVERAGE_DECREASED →Transitioned To · WST CAPEX_INTENSITY_DECREASED →Transitioned To · WST CASH_GENERATION_INCREASED →Transitioned To · WST GROWTH_INCREASED →Transitioned To · WST INVENTORY_PRESSURE_INCREASED →Transitioned To · WST MARGIN_INCREASED →Transitioned To · WST PROFITABILITY_INCREASED →Transitioned To · WST R_AND_D_INTENSITY_INCREASED →Transitioned To · WST SBC_INTENSITY_INCREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.